Drugs / Triamcinalone
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 11 trial | ||||||
| Phase 1 | NCT00186108 | Oct 2002 → Sep 2005 | prostate cancer | Stanford University | Completed | No outcome recorded |
| Phase 41 trial | ||||||
| Phase 4 | NCT02001740 | Dec 2012 → Mar 2015 | frozen shoulder | Queen's University | Completed | No outcome recorded |
| Comparator or background therapy1 trial | ||||||
| Phase 1/2 | NCT07454772 Background | Mar 2026 → Apr 2027 expected | granulomatous mastitis | All India Institute of Medical Sciences, Bhubaneswar | Not yet recruiting | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Triamcinalone | “intralesional steroids (Inj. Triamcinalone 40mg)” NCT07454772 ↗ |
| Known as | Inj. Triamcinalone | “intralesional steroids (Inj. Triamcinalone 40mg)” NCT07454772 ↗ |
| Modality | Small molecule | “Triamcinalone (steroid)” NCT02001740 ↗ |
| Route | Oral | “oral triamcinalone given twice a day” NCT00186108 ↗ |